STREAMING NOW: Watch Now

Experimental treatment uses modified stem cells to fight cancer

A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient's ow...

Posted: Jul 20, 2018 6:18 PM
Updated: Jul 20, 2018 6:18 PM

A clinical trial run by UCLA is testing a potentially pioneering form of immunotherapy that could turn a patient's own body into a powerful weapon against cancer.

Researchers at the university's Jonsson Comprehensive Cancer Center are reinforcing the immune system's foundation by genetically modifying bone marrow stem cells, the cellular factories that power immune responses. By arming those cells with receptors that recognize cancer, researchers hope a patient's body will cure itself from the inside out.

Dr. Antoni Ribas, who is leading the trial, started working on cancer immunotherapy -- treatments that alter a patient's immune response to fend off cancer -- more than 20 years ago. He played a key role in the clinical development of Keytruda, Merck's popular immunotherapy drug used to treat several types of cancer including some types of melanoma (a type of skin cancer), Hodgkin's disease, some head and neck cancers, some non-small cell lung cancers, and some colorectal cancers. Now he's turning his attention to another therapy he finds especially exciting.

The immune system defends the body against sickness. T-cells play an integral role. They're a type of white blood cell that seeks out and destroys diseased cells. The trouble is, T-cells don't recognize cancerous cells as an adversary, leaving the body vulnerable.

Researchers already know how to get around that by extracting T-cells and adding the genetic code for receptors that detect cancer. The problem? Eventually those super-powered T-cells stop working. "We realized the immune system cells that we give back have a limited life span," Ribas said.

That's where the UCLA trial comes in.

Bone marrow stem cells are the factories that produce new T-cells. But rather than simply genetically modifying T-cells, Ribas is modifying the bone marrow stem cells that make them. In other words, he's modifying the car factory, not just the car.

The result, in theory, is a lifetime supply of cancer-fighting T-cells and, hopefully, a more cancer-resistant immune system. Testing that theory will require years of clinical trials. Daniel Apodaca, 25-year-old UCLA student who has epithelioid sarcoma, a rare, soft tissue cancer that grows slowly, became the trial's first patient in April.

"I didn't have any options before," Apodaca told CNNMoney. "So just having an option in general, I feel really lucky."

Ribas said doctors extracted some of Apodaca's bone marrow stem cells along with a batch of T-cells and modified them in the lab. Chemotherapy helped eradicate his existing immune system cells, making room for the new and improved ones. The immune system reboot kept Apodaca in a sterile hospital environment for three weeks. When he left on April 24th with his reprogrammed immune system, doctors called it his second birthday. But it will be years before they can definitively say the treatment worked.

Beyond the uncertainty inherent in any experimental treatment, immunotherapies come with risks and side effects, such as colitis, or colon inflammation, infection, or even a severe or fatal allergic reaction, although that's rare. And cell therapy carries the possibility that the upgraded immune system could attack healthy tissues, said Fred Ramsdell, Vice President of Research at the Parker Institute for Cancer Immunotherapy.

"As we try to amp up the immune system, we do run the risk of having the immune system recognize some of our normal tissues," and attack them, he said.

If that happens, "we'll pull the safety mechanism," Ribas said. "We [insert] a gene that allows us to kill them if they become bad."

Despite the risk, the therapy could advance the field of immunotherapy, Ramsdell said. "We need to find ways to sustain the effect of adapted cell therapies," he said. "This trial is pushing the envelope."

Achieving that progress took more than a decade of research and millions of dollars, Ribas said. The California Institute for Regenerative Medicine, a taxpayer-funded research organization, financed the trial with a $20 million grant.

Ribas estimates the therapy could cost hundreds of thousands of dollars per patient. And even if it works, big questions remain about its wider application. The key to an effective targeted immunotherapy is detecting the unique signature of a patient's specific cancer and matching it with a receptor that doctors can add to a T-cell. That's how the modified T-cell knows to attack the cancerous cells, not healthy cells. But the process of matching cancer signatures and receptors has proven difficult, and the list of matches remains relatively short.

"Our first attempt is targeting in particular two cancers, sarcomas and melanomas, because they have a protein called NY-ESO-1 that can be efficiently targeted with a receptor that we have," Ribas said. "Potentially, we could do more, but every time we use a new receptor we would have to go back to the beginning."

For now, Apodaca is responding well enough to visit his girlfriend who is finishing up school in Spain. And he manages to stay optimistic about the future. "Hopefully I become the golden child for this amazing scientific movement," he said. "I look to see some real progress in medicine and for oncology, potentially for all subtypes of cancer."

That movement remains a long way off. The therapy faces several more clinical trials and rigorous FDA review before it enters widespread use. That is, if it works. And that's a big if. But such is the nature of medical research. "That's where we push the limits of science," Ribas said. "If we don't do things like this, then we don't advance."

Indiana Coronavirus Cases

Data is updated nightly.

Cases: 295357

Reported Deaths: 5305
CountyCasesDeaths
Marion40796844
Lake25864448
Allen17025289
Elkhart16389209
St. Joseph16125217
Hamilton12225163
Vanderburgh9218112
Tippecanoe807627
Porter770176
Johnson5971161
Hendricks5719154
Vigo563274
Monroe519846
Clark486774
Delaware4721103
Madison4651119
Kosciusko437339
LaPorte436792
Howard321375
Warrick309072
Floyd301177
Bartholomew296262
Wayne292261
Cass291231
Marshall283642
Grant254147
Noble244246
Hancock238949
Henry234136
Boone231754
Dubois229230
Dearborn204629
Jackson200033
Morgan196043
Gibson171622
Knox170715
Clinton170420
Shelby170453
Lawrence169246
DeKalb168428
Adams160019
Miami150414
Daviess149143
Wabash148118
Fayette141233
Steuben139713
LaGrange135127
Jasper134911
Harrison134624
Montgomery127926
Whitley127410
Ripley121414
Decatur119842
Posey116613
Putnam115626
Wells115427
Huntington115210
White115221
Randolph114619
Clay111821
Jefferson110314
Scott97918
Greene97553
Jay93012
Starke87021
Sullivan85515
Perry80521
Spencer7957
Jennings79114
Fulton78717
Fountain7257
Washington6966
Carroll65313
Orange64828
Franklin63525
Owen5676
Vermillion5662
Newton53412
Parke5296
Tipton52826
Blackford50011
Rush5006
Pike49618
Pulaski36410
Martin3425
Brown3153
Benton3101
Crawford2711
Union2551
Switzerland2453
Warren2272
Ohio2227
Unassigned0265

Ohio Coronavirus Cases

Data is updated nightly.

Cases: 351419

Reported Deaths: 5996
CountyCasesDeaths
Franklin48389665
Cuyahoga34096734
Hamilton28674371
Montgomery19082225
Butler14138144
Lucas13446406
Summit12431309
Stark8122197
Warren770375
Mahoning6772299
Lake625466
Lorain590297
Clermont541946
Delaware521435
Licking506275
Fairfield505163
Trumbull4969144
Greene489662
Clark486664
Marion451451
Allen446384
Wood4243107
Medina413354
Miami398565
Pickaway387948
Columbiana328496
Portage323171
Wayne303593
Tuscarawas299557
Richland293929
Mercer281237
Ross234559
Hancock225336
Muskingum223610
Auglaize218925
Putnam218649
Darke208058
Erie205565
Ashtabula204753
Geauga189451
Scioto186713
Lawrence181336
Athens17954
Union17928
Shelby176715
Seneca165018
Belmont151529
Madison151018
Sandusky144427
Preble143821
Huron139218
Holmes137039
Defiance131121
Knox118818
Logan118313
Fulton117225
Ottawa114730
Crawford114216
Washington112427
Clinton100314
Williams9938
Jefferson9894
Ashland98322
Highland96317
Henry94422
Brown9324
Champaign8935
Jackson87312
Fayette86617
Van Wert8596
Morrow8312
Hardin82518
Guernsey79213
Coshocton78813
Perry73312
Pike7081
Adams70611
Wyandot68916
Gallia68113
Paulding61710
Hocking58511
Noble56121
Carroll41610
Meigs36312
Monroe29921
Morgan2342
Vinton2075
Harrison1823
Unassigned00
Fort Wayne
Few Clouds
30° wxIcon
Hi: 46° Lo: 29°
Feels Like: 30°
Angola
Clear
28° wxIcon
Hi: 44° Lo: 27°
Feels Like: 28°
Huntington
Clear
32° wxIcon
Hi: 44° Lo: 30°
Feels Like: 32°
Decatur
Clear
32° wxIcon
Hi: 46° Lo: 31°
Feels Like: 32°
Van Wert
Clear
32° wxIcon
Hi: 46° Lo: 30°
Feels Like: 32°
Snow/Rain Showers Tuesday
WFFT Radar
WFFT Temperatures
WFFT National

Community Events